(via Thenewswire.ca)
Moncton, NB / TNW-ACCESSWIRE / September 4 2014 / OrganiGram Holdings Inc (TSX.V:OGI) CEO Denis Arsenault participated in an audio podcast interview with James West of MidasLetter.com. The interview was published yesterday and is available through iTunes and MidasLetter.com.
"At the end of the day, we're selling an organic product, and we know that that resonates well with the doctors, and just with the general population," said Arsenault in the interview.
Listen to the full interview here or read the full transcript of the interview here: http://www.midasletter.com/?p=9321
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed company who's wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.
Please visit www.organigram.ca for more information.
About MidasLetter.com
Midas Letter is the global investment journal of emerging companies with 'best-in-class' potential across all sectors. MidasLetter's James West has been delivering critical intelligence for investors in all sectors from inside the Emerging Company segment of public markets in cutting edge formats for nearly 20 years.
MidasLetter provides subscribers with advanced market intelligence on new issuers, and focuses on identifying only those with the potential to become industry leaders in their respective sectors.
Visit http://www.midasletter.com/subscribe to learn more.
Copyright (c) 2014 TheNewswire - All rights reserved.